SOPHSOPHiA GENETICS SA
$7.30+75% 1Y
$7.30
$3.8952 weeks$8.90
The financials
SOPHiA GENETICS SA by the numbers
SOPHiA GENETICS SA (SOPH) reported revenue of $41M in H2 2025 (quarter ended Dec 31, 2025), up 160% from the same quarter a year earlier. That came with a gross margin of 67% and net loss of $39M. For the full year FY2025, revenue was $77M (+19% year on year) and net income −$79M.
| Income statement | H2 2025 | Q2 2024 | Change |
|---|---|---|---|
| Revenue | $41M | $16M | +160% |
| Gross profit | $28M | $11M | +156% |
| Operating income | −$36M | −$15M | n/a |
| Net income | −$39M | −$15M | n/a |
| Diluted EPS | −$0.58 | −$0.23 | n/a |
Health Information Services
Ranks #13 of 20 by RyuScore